← SynDRA
CG-400549
SynDRA canonical compound SYN0016580 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Mechanism of action | FABI inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- FABI inhibitor
- Stap-coc fabI INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- Nilofabicin
- CG400549
- CG-400459
- CG-400329
- CG-400462
- CG-400587
- Bacterial enoyl-ACP reductase inhibitors, CrystalGenomics
- FabI inhibitors (antibacterial), CrystalGenomics
- FabK inhibitors (bacterial infections, oral), CrystalGenomics
- CG 400549
- 4X6T64D64X
- RefChem:124754
- DTXCID20161925
- MFCD09991584
- UNII-4X6T64D64X
- PT6
- NILOFABICIN [INN]
- orb1306955
- SCHEMBL2177308
- SCHEMBL29385717
- GTPL10984
- BDBM231620
- EX-A10800
- AKOS015842354
- AS-35976
- DB-012662
- HY-111071
- CS-0034149
- NS00071547
- T19642
- F301600
- BRD-K48888725-001-01-9
- BRD-K48888725-001-02-7
Look up CG-400549 in the interactive SynDRA portal →